Stocks · News reference
iSpecimen, a provider of human biospecimens, recently completed an international cancer research project involving hundreds of cancer blood specimens, with the samples shipped within three weeks of receiving the
Reference Details
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
Keep reading
On September 4, 2026, iSpecimen Inc., a Delaware corporation (the "Company"), entered into an Asset Purchase Agreement (the "Agreement") with Foldlab AI Ltd., a company organized under the laws of
Filed: 2026-09-04 AccNo: 0001213900-26-097726 Size: 625 KB Item 1.01: Entry into a Material Definitive Agreement Item 9.01: Financial Statements and Exhibits
US stocks rise, Dow gains over 350 points as markets open Friday; Materials sector up 2%, utilities down 0.3%. BJ's Wholesale Club beats earnings expectations and raises guidance.